The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults and pediatric patients with congenital thrombotic thrombocytopenic purpura, a rare blood ...

Thrombocytopenia is an atypically low platelet count. Acquired thrombocytopenia is caused by conditions that develop throughout your life instead of genes inherited from birth. Acquired ...

JUNEAU – On May 21, 2007, then seventh grader Chelsey Goeman woke up for her First Communion covered in blood. “There was blood everywhere that I had coughed through the night, but I don’t remember ...

Protein C deficiency is a heritable disorder that compromises the natural anticoagulant system, thereby increasing the risk of thromboembolic events such as deep venous thrombosis, pulmonary embolism ...

A 49-year-old woman, previously recuperating from COVID-19, was found unconscious at her workplace, setting off a chain of events that would ultimately lead to an unexpected diagnosis. This case ...